GabrielLarkinSicaMDPhD

Pulmonary Pathology

Physician

Dr. Sica is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2004 - 2007
Brown UniversityInternship, Internal Medicine, 2003 - 2004
Mayo Clinic College of MedicineClass of 2003

PubMed

243 citations
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Mihir Trivedi, Anne B. Richardson
Cell Systems. 2018-03-28
121 citations
Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study.
Taofeek K. Owonikoko, Suzanne E. Dahlberg, Gabriel Sica, Lynne I. Wagner, James L. Wade
Journal of Clinical Oncology. 2017-05-30
66 citations
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer
Taofeek K. Owonikoko, Guojing Zhang, Xingming Deng, Michael R. Rossi, Jeffrey M. Switchenko
Cancer Medicine. 2014-12-01

Journal Articles

Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with Radiotherapy
Gabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer